Protection against Human Immunodeficiency Virus Type 1 Tat Neurotoxicity by Ginkgo biloba Extract EGb 761 Involving Glial Fibrillary Acidic Protein

This publication has 64 references indexed in Scilit:

• Inhibition of Aldose Reductase Prevents Lipopolysaccharide-Induced Inflammatory Response in Human Lens Epithelial Cells
  Investigative Opthalmology & Visual Science, 2006
• Gene expression analysis in mice with elevated glial fibrillary acidic protein and Rosenthal fibers reveals a stress response followed by glial activation and neuronal dysfunction
  Human Molecular Genetics, 2005
• Effects ofGinkgo biloba extract (EGb 761) on gene expression: Possible relevance to neurological disorders and age-associated cognitive impairment
  Drug Development Research, 2002
• Interleukin-1, neuroinflammation, and Alzheimer's disease
  Neurobiology of Aging, 2001
• Flavonoid Baicalin Inhibits HIV-1 Infection at the Level of Viral Entry
  Biochemical and Biophysical Research Communications, 2000
• Motor Function in Young and Aged Hemiplegic Rats: Effects of a Ginkgo Biloba Extract
  Neurobiology of Aging, 1997
• AIDS dementia complex and HIV‐1 brain infection: Clinical‐virological correlations
  Annals of Neurology, 1995
• Ginkgo Biloba Extract (EGb 761) Protects Human Low-Density Lipoproteins against Oxidative Modification Mediated by Copper
  Biochemical and Biophysical Research Communications, 1995
• Ginkgo biloba extract facilitates recovery from penetrating brain injury in adult male rats
  Experimental Neurology, 1989
• Effects of a platelet activating factor antagonist (BN 52021) on free fatty acids, diacylglycerols, polyphosphoinositides and blood flow in the gerbil brain: Inhibition of ischemia-reperfusion induced cerebral injury
  Biochemical and Biophysical Research Communications, 1987